Medsintez Plant participated in a key industry event, Product Innovation Fair in Medicine and Healthcare, which took place in Moscow on October 29–30. Viktor Fisenko, First Deputy Minister of Healthcare of Russia, attended the exhibition of domestic innovations in the field of drugs and medical products.
The 3d Scientific and Practical Conference The Ural Peaks. Respiratory Infections 2025 was held in Ekaterinburg on October 15–16 as part of the 4th International Forum Days of Virology 2025. The event organized by the Ministry of Health of the Sverdlovsk Region, the Smorodintsev Research Institute of Influenza, and the Ural State Medical University brought together over 1,100 participants in person and online from 36 cities across Russia.
In September 2025, the Russian Ministry of Health issued a registration certificate for a new dosage form of the broad-spectrum antiviral drug TRIAZAVIRIN® for the treatment of ARVI in school-age children—100 mg.
On October 10, 2025, a representative delegation visited the Medsintez Plant. Among the visitors, there were members of the State Duma of the Russian Federation, representatives of the Government and Legislative Assembly of the Sverdlovsk Region, the head of the Novouralsk Urban District, and leading regional experts in the field of medical science. The main purpose of the visit was to assess the enterprise's success in import-substituting drug production, become familiar with its brand-new products, and discuss development options of the pharmaceutical industry in the region.
The institute includes 5 laboratories and 4 groups. On the basis of the Institute of Organic Synthesis, there are branches of the Departments of Organic Chemistry of the Ural Federal University, joint laboratories with the Department of High- Molecular Compositions of the Ural Federal University and the Faculty of Chemistry of the Chelyabinsk State University, Research Equipment Sharing Center of the Ural Branch of the Russian Academy of Sciences “Spectroscopy and Organic Compound Analysis”, laboratory of the Ural Scientific and Educational Center “Advanced Materials”.
Development of the Institute is
based on the following
guidelines:
1. Combining the best traditions
of the Urals scientific school of
organic chemists with
innovative approaches to
development of fundamental
research aimed at creating new
methodologies for organic
synthesis, taking into account
the latest achievements of world science in such important
areas as C-H functionalization
of aromatic and heteroaromatic
substances, synthesis of
enantiomerically pure
biologically active compounds,
chemistry of fluorine-containing
compounds, chemistry of
organo(boron)element
compounds, asymmetric
catalysis, supramolecular and
coordination chemistry,
transformations of
heterocycles, electro- and
photosynthesis, chemistry of
monomers and polymers, gas-,
oil- and coal chemistry.
2. Reasonable balance of
fundamental and applied
research.
Development of fundamental
research in organic synthesis,
focused on creation of drugs
combating infectious diseases
of viral and bacterial etiology,
including those active against
viruses, bacteria and
mycobacteria with multidrug
resistance, as well as
anticancer, anti-inflammatory
and other chemotherapeutic
agents.
Medical and biological studies
of drugs as part of preclinical
and clinical studies thereof.
3. Development of fundamental
and applied research in the
field of organic materials
science, as the most important direction of the Strategy for
Scientific and Technological
Development of the Russian
Federation.
Strengthening cooperation with
universities and enterprises of
the real sector of economy.
Carrying out a full cycle of
research and development
applied work to create new
organic materials for medicine
and technology, including for
enterprises of the military-
industrial complex, including
development of materials,
methods and technologies for
production thereof.